Weekly report of trade and retail industry: the annual net profit of one leaf transferred to effective skin care Yunnan Botanee Bio-Technology Group Co.Ltd(300957) is expected to increase by 51-64%

Shanghai Shangmei’s IPO in Hong Kong, a leaf of transforming efficacy skin care for consumption pain points: Shanghai Shangmei Cosmetics Co., Ltd. disclosed the prospectus submitted to the Hong Kong Stock Exchange on January 17. The company is going to be listed on the main board of Hongkong, and its brand is one of the latest products in the near future. Oneleaf is the first brand to promote China’s pure beauty plant repair. Shanghai Shangmei is the only domestic cosmetics company with two skin care brands with annual retail sales of more than 2 billion yuan in 2020. Its products and brand matrix are perfect and has strong brand incubation ability. After listing and raising funds, the company has further deepened its brand marketing, star endorsement, R & D, production and supply chain, and is optimistic about the company’s brand transformation and the layout of emerging e-commerce channels.

Release of 2021 annual performance forecast for multiple targets: 1) Yunnan Botanee Bio-Technology Group Co.Ltd(300957) release of 2021 annual performance forecast: the net profit attributable to the parent company is expected to increase by 51-64%, and the single brand is far from the “ceiling”: the company released the 2021 performance forecast, and it is expected to realize the net profit attributable to the parent company of RMB 820-890 million in 2021, with a year-on-year increase of 50.87% – 63.75%. Net profit deducted from non parent company was RMB 770-840 million, with a year-on-year increase of 50.20% – 63.85%. The sub brand Winona baby21 radiated specific groups through the offline professional channels of the yuezi club in the 21st year, and entered the top10 of tmall baby skin care category on the double eleventh day. The sub brand aoxmed is positioned as a high-end brand. It is expected that the city will enter through the medical beauty channel in May. The company will actively seek extension investment in upstream and downstream related projects. As for the Yunnan characteristic plant extraction laboratory, it is expected to be industry-oriented, focus on using the resources of Yunnan characteristic plants, make industrial R & D breakthroughs in functional skin care products, functional foods and future drugs, and drive the development of local plant industry, In the future, the company is expected to build it into an internal R & D service expansion platform. 2) Fujian Green Pine Co.Ltd(300132) released the performance forecast for 2021: the short-term profit of goodwill impairment is under pressure, and the performance is waiting for the inflection point: in 2021, the company is expected to achieve an operating revenue of 3.6 ~ 3.8 billion yuan, a year-on-year decrease of 1.68% ~ 6.85%, and the net profit attributable to the parent company is about 820 ~ 920 million yuan, a year-on-year decrease of 277.95% ~ 299.65%. The amount of impairment provision for goodwill and long-term assets proposed by the company is 860 ~ 960 million yuan, The decline in performance was mainly affected by the significant adverse impact of goodwill and impairment of long-term assets. 3) Guangdong Chj Industry Co.Ltd(002345) release the announcement of annual performance forecast in 2021: the company is expected to realize a net profit attributable to the parent company of RMB 330-350 million in 2021, with a year-on-year increase of 136.23% – 150.55%. In Q4 of 2021, the net profit attributable to the parent company is expected to be 44.985-64.985 million yuan, with a year-on-year increase of – 23.82% – 10.10%. The significant increase in the annual performance is mainly due to the company’s customers and market strategy.

Investment suggestions: medical policies regulate the operation of downstream entities, promote the standardized and healthy development of the medical and beauty industry, continue to focus on recommending upstream compliance leaders Imeik Technology Development Co.Ltd(300896) , Bloomage Biotechnology Corporation Limited(688363) , and pay attention to downstream terminal institutions Lancy Co.Ltd(002612) , Aoyuan Beauty Valley Technology Co.Ltd(000615) ; The cosmetics industry recommends Yunnan Botanee Bio-Technology Group Co.Ltd(300957) , Proya Cosmetics Co.Ltd(603605) , and traditional domestic products Shanghai Jahwa United Co.Ltd(600315) , which are fully developed in brands, products and channels. It is suggested to pay attention to Nanjing Cosmos Chemical Co.Ltd(300856) , Jahen Household Products Co.Ltd(300955) , which have marginal improvement logic and are expected to benefit from industrial policies.

Risk tip: weak consumer demand as a whole, intensified industry competition, etc

- Advertisment -